OMF 2019 Year in Review

OMF 2019 Year in Review
Organizational Accomplishments We Welcomed:

  • New SAB members: Alain Moreau, PhD and Michael Snyder, PhD
  • New Chief Medical Officer: Ronald Tompkins, MD, ScD
  • New VP of Philanthropy: Kathleen Morgen
  • New Ambassadors: Karin Alvtegen and Jaqueline Ko

We also:

  • Launched a new ME/CFS Collaborative Research Center at Uppsala University in Sweden
  • Sponsored two productive scientific symposia at Stanford and Harvard
  • Sponsored two Community symposia
  • Provided free live streaming at Stanford Community symposium
  • Funded high-level research on multiple projects
  • Established OMF Canada
  • Assembled Harvard-affiliated Clinicians to explore new collaborations
    among specialists

ME/CFS Collaborative Research Center Updates
Your 2019 contribution funded open and collaborative research across the globe, conducted with impeccable standards and integrity, by researchers and clinicians of the highest caliber.

Stanford UniversityCollaborative Research Center

Directed by Ronald W. Davis, PhD
Professor of Biochemistry and Genetics
Open Medicine Foundation has been the lead funding partner of Dr. Davis’s ME/CFS research team at Stanford University since 2014

019 Research Focus:

  • Nanoneedle technology development
  • Technology to detect Red Blood Cell Deformability
  • Tryptophan Metabolic Trap
  • Trace heavy metal detection
  • Developement of a new test to expand the number of pathogens detectable in cell free DNA/RNA
  • Direct DNA sequencing of genes possibly connected to ME/CFS

2019 Publications Include:

Please visit our website for more information about projects at the Stanford CRC 2019 End of Year Message from Ronald W. Davis, PhD, and Janet L. Dafoe, PhD

Harvard Affiliated Hospitals
Collaborative Research Center

Co-Directed by Ronald G. Tompkins, MD, ScD
Sumner M. Redstone Professor of Surgery, Harvard Medical School Founding Director

Co-Directed by Wenzhong Xiao, PhD
Assistant professor of Bioinformatics and Director of the Inflammation & Metabolism Computational Center at Massachusetts General Hospital  In 2018, OMF launched a funding partnership with Harvard affiliated hospitals, including Massachusetts General Hospital (MGH), Brigham and Women’s Hospital (BWH), and Beth Israel Deaconess Medical Center (BIDMC).
This research collaboration seeks to conduct clinical and basic science studies to characterize the dynamic biological changes that occur during a change in symptom expression of ME/CFS patients

Projects launched in 2019 include:

  • BWH iCPET biorepository plasma proteomic and metabolomic studies
  • PASS/CAT diagnostic tool development
  • Symposiums Science and Community

Please visit our website for more information about projects at the Harvard CRC

Uppsala University, Sweden

Collaborative Research Center Directed by Jonas Bergquist, MD, PhD
Full Chair Professor in Analytical Chemistry and Neurochemistry In 2019, OMF funded and launched the ME/CFS Collaborative Research Center at Uppsala University under the direction of Jonas Bergquist, MD, PhD. This new Collaborative Center focuses on the targeted molecular diagnosis of ME/CFS with the goal of evidence-based strategies for interventions. Current projects include:

  • Kynurenine studies in ME/CFS
  • Autoimmunity aspects of ME/CFS
  • Endocrine hormone disturbances in ME/CFS

Please visit our website for more information about projects at the Uppsala CRC


Комментариев нет